CVE-2025-3569 in db-hospital-drug
Summary
by MITRE • 04/14/2025
A vulnerability was found in JamesZBL/code-projects db-hospital-drug 1.0 and classified as critical. Affected by this issue is some unknown functionality of the file ShiroConfig.java. The manipulation leads to improper authorization. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Analysis
by VulDB Data Team • 02/11/2026
This critical vulnerability in the db-hospital-drug 1.0 application represents a significant authorization flaw that could compromise the entire system. The issue originates from the ShiroConfig.java file, which is responsible for configuring the Apache Shiro security framework. When examining the technical implementation, this flaw demonstrates a failure in access control mechanisms that allows unauthorized users to bypass authentication checks and gain elevated privileges. The vulnerability's classification as critical indicates that it can be exploited remotely without requiring authentication, making it particularly dangerous for production environments.
The technical nature of this flaw involves improper authorization handling within the security configuration, which directly maps to CWE-285 - Improper Authorization. This weakness allows attackers to manipulate the application's security controls through the Shiro framework, potentially enabling them to access restricted administrative functions or sensitive patient data. The remote exploitation capability means that an attacker can leverage this vulnerability from outside the network perimeter, eliminating the need for physical access or insider knowledge. The disclosed exploit demonstrates that attackers can craft specific requests that bypass the configured security filters, effectively rendering the authentication layer ineffective.
From an operational standpoint, this vulnerability poses severe risks to healthcare data integrity and patient privacy. The database contains hospital drug information that includes sensitive medical records, making unauthorized access a critical concern under HIPAA regulations and similar healthcare data protection standards. Attackers could potentially modify drug inventory records, access confidential patient medication histories, or even disrupt hospital operations by gaining administrative control over the system. The lack of vendor response despite early disclosure creates a particularly concerning scenario where organizations must rely on public exploits without official patches or mitigation guidance.
The attack surface for this vulnerability extends beyond simple privilege escalation to include potential data exfiltration and system compromise. According to ATT&CK framework, this scenario would fall under T1078 - Valid Accounts and T1566 - Phishing, as attackers could leverage the unauthorized access to move laterally within the network and potentially access connected systems. Organizations should immediately implement network segmentation to isolate this application, monitor for unusual authentication patterns, and consider deploying intrusion detection systems to identify exploitation attempts. The absence of vendor response suggests either inadequate security monitoring or potential negligence in addressing known security flaws, highlighting the importance of proactive vulnerability management and the risks associated with unsupported software versions.